Skip to main content
Log in

Molecular mechanisms of chronic rejection following transplantation

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Although significant advances have been made in the field of organ transplantation, chronic rejection remains a major limiting factor for prolonged graft survival. The long-term survival and function of transplanted lungs are limited by the development of bronchiolitis obliterans syndrome (BOS). The 10-yr lung graft survival rate is only 18.6%. Aside from results of several clinical studies that strongly support the concept that BOS results from alloimmune-mediated injury, little is known regarding specific immune effectors or target molecules involved in the pathogenesis of BOS. Studies from our laboratory have provided evidence for the seminal role of CD4+ T-cells in the pathogenesis of obliterative airway disease (OAD) seen in BOS. Prior to any clinically detectable lesions, there is indirect antigen presentation of mismatched major histocompatibility complex (MHC) class I antigen and production of antibodies to these MHC antigens. Both MHC and minor histocompatibility antigen disparities can result in the development of OAD in animal models and preliminary results strongly suggest that peptide vaccination strategies may prevent OAD following heterotopic tracheal transplants. Using a newly developed orthotopic tracheal transplant model, we have obtained evidence for an important and probably exclusive role for airway epithelial cell injury as a primary mechanism for the immunopathogenesis of the development of OAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Trulock EP, Edwards LB, Taylor DO, et al: The registry of the International Society for Heart and Lung Transplantation: Twentieth Official adult lung and heart-lung transplant report—2003. J Heart Lung Transplant 2003;22:625–635.

    Article  PubMed  Google Scholar 

  2. Valentine VG, Robbins RC, Berry GJ, et al: Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996;15:371–383.

    PubMed  CAS  Google Scholar 

  3. Sherman LA, Chattopadhyay S: The molecular basis of allorecognition. Annu Rev Immunol 1993;11:385–402.

    Article  PubMed  CAS  Google Scholar 

  4. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE: Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992;175:305–308.

    Article  PubMed  CAS  Google Scholar 

  5. Fangmann J, Dalchau R, Fabre J: Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992;175:1521–1529.

    Article  PubMed  CAS  Google Scholar 

  6. Waaga AM, Chandraker A, Spadafora-Ferreira M, et al: Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection. Transplantation 1998;65:876–883.

    Article  PubMed  CAS  Google Scholar 

  7. Benham AM, Sawyer GJ, Fabre JW: Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts. Transplantation 1995;59:1028–1032.

    Article  PubMed  CAS  Google Scholar 

  8. Vella JP, Spadafora-Ferreira M, Murphy B, et al: Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997;64:795–800

    Article  PubMed  CAS  Google Scholar 

  9. Liu Z, Colovai AI, Tugulea S, et al: Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996;98:1150–1157.

    Article  PubMed  CAS  Google Scholar 

  10. Molajoni ER, Cinti P, Orlandini A, et al: Mechanism of liver allograft rejection: the indirect recognition pathway. Hum Immunol 1997;53:57–63.

    Article  PubMed  CAS  Google Scholar 

  11. Liu Z, Harris PE, Coloval AI, Reed EF, Maffei A, Suciu-Foca N: Indirect recognition of donor MHC class II antigens in human transplantation. Clin Immunol Immunopathol 1996;78:228–235.

    Article  PubMed  CAS  Google Scholar 

  12. Rizzo M, Sundaresan S, Lynch J, et al: Increased concentration of soluble human leukocyte antigen class I levels in the bronchoalveolar lavage of human pulmonary allografts. J Heart Lung Transplant 1997;16:1135–1140.

    PubMed  CAS  Google Scholar 

  13. SivaSai KSR, Smith MA, Poindexter N, et al: Indirect recognition of donor HLA class I peptides in lung transplantation recipients with bronchiolitis obliterans syndrome. Transplantation 1999;67:1094–1098.

    Article  PubMed  CAS  Google Scholar 

  14. Reznik SI, Jaramillo A, SivaSai KSR, et al: Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 2001;1:228–235.

    Article  PubMed  CAS  Google Scholar 

  15. Smith MA, Jaramillo A, SivaSai KSR, et al: Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts. Transplantation 2002;73:186–193.

    Article  PubMed  CAS  Google Scholar 

  16. Higuchi T, Jaramillo A, Kaleem Z, Patterson GA, Mohanakumar T: Different kinetics of obliterative airway disease development induced by CD4+ and CD8+ T cells in murine heterotopic tracheal allografts. Transplantation 2002;74:646–651.

    Article  PubMed  CAS  Google Scholar 

  17. Sundaresan S, Mohanakumar T, Smith MA, et al: HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 1998;65:648–653.

    Article  PubMed  CAS  Google Scholar 

  18. Smith MA, Sundaresan RS, Mohanakumar T, et al: Effect of development of antibodies to HLA and CMV mismatch on lung transplant survival and development of bronchiolitis obliterans syndrome. Am J Thorac Surg 1998;116:812–820.

    CAS  Google Scholar 

  19. Jaramillo A, Smith MA, Phelan D, et al: Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 1999;67:1155–1161.

    Article  PubMed  CAS  Google Scholar 

  20. Reznik SI, Jaramillo A, Zhang L, Patterson GA, Cooper JD, Mohanakumar T: Anti-HLA antibody binding to HLA class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 2000;119:39–45.

    Article  PubMed  CAS  Google Scholar 

  21. Jaramillo A, Smith CR, Zhang L, Patterson GA, Mohanakumar T: Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol 2003;64:521–529.

    Article  PubMed  CAS  Google Scholar 

  22. Kubota H, Yagyu K, Takeshita OM, Furuse A: Importance of bronchus-associated lymphoid tissue and major histocompatibility complex class I and II antigen expression on bronchial epithelium in acute lung allograft rejection and lung infection in rats. Transplant Proc 1994;26:1856–1858.

    PubMed  CAS  Google Scholar 

  23. Mauck KA, Hosenpud JD: The bronchial epithelium: a potential allogenic target for chronic rejection after lung transplantation. J Heart Lung Transplant 1996;15:709–714.

    PubMed  CAS  Google Scholar 

  24. Adams BF, Brazelton T, Berry GJ, Morris RE: The role of respiratory epithelium in a rat model of obliterative airway disease. Transplantation 2000;69:661–664.

    Article  PubMed  CAS  Google Scholar 

  25. Genden EM, Boros P, Liu J, Bromberg JS, Mayer L: Orthotopic tracheal transplantation in the murine model. Transplantation 2002;73:1420–1425.

    Article  PubMed  Google Scholar 

  26. Fernandez FG, Jaramillo A, Chang C, et al: Airway epithelium is the primary target of allograft rejection immurine obliterative airway disease. Am J Transplant 2004;4:319–325.

    Article  PubMed  Google Scholar 

  27. Zhang L, Irion K, Kozakewich H, et al: Clinical course of postinfectious bronchiolitis obliterans. Cochrane Database Syst Rev 2000;2:341–350.

    Google Scholar 

  28. Hirschheimer M, Silva PS, Giudici R, Carrilho M, Mauad T, Ishida M: Simultaneous viral infection and childhood bronchiolitis obliterans. Braz J Infect Dis 2002;6:146–148.

    Article  PubMed  Google Scholar 

  29. Penn CC, Liu C: Bronchiolitis following infection in adults and children. Clin Chest Med 1993;14:645–654.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuo, E., Maruyama, T., Fernandez, F. et al. Molecular mechanisms of chronic rejection following transplantation. Immunol Res 32, 179–185 (2005). https://doi.org/10.1385/IR:32:1-3:179

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/IR:32:1-3:179

Key Words

Navigation